Shanghai Xiao Fang Pharmaceutical Co.,Ltd. (SHA:603207)
China flag China · Delayed Price · Currency is CNY
22.12
+0.31 (1.42%)
At close: Oct 23, 2026

SHA:603207 Cash Flow Statement

Millions CNY. Fiscal year is Jan - Dec.

Operating Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Income
193.15207.49205.27203.63175.18126.27
Depreciation & Amortization
2.672.682.813.233.654.17
Other Amortization
0.110.110.230.290.250.24
Loss (Gain) From Sale of Assets
-0.11-0.11---0-
Asset Writedown & Restructuring Costs
----0.270.06
Loss (Gain) From Sale of Investments
---0.02-2.25-2.96-2.83
Stock-Based Compensation
2.912.910.791.994.0843.78
Provision & Write-off of Bad Debts
1.851.850.220.171.37-0.71
Other Operating Activities
52.04-0.360.10.130.050.08
Change in Accounts Receivable
-42.2-48.72-6.76-4.39-33.6812.74
Change in Inventory
-24.16-24.164.617.2-4.12-13.25
Change in Accounts Payable
13.9120.435.45-9.15-6.639.51
Operating Cash Flow
198.87160.8212.21200.26137.2179.51
Operating Cash Flow Growth
11.43%-24.23%5.97%45.96%-23.57%1.37%

Investing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Capital Expenditures
-71.69-54.24-83.94-80.15-61.59-12.48
Sale of Property, Plant & Equipment
-0.11---0.46
Investment in Securities
-22.14356-450.1107.2754.02-97.57
Other Investing Activities
3.984.143.09-0.720.95.19
Investing Cash Flow
-89.86306.01-530.9526.4-6.67-104.4

Financing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Short-Term Debt Issued
-1.121.65---
Total Debt Issued
1.121.121.65---
Long-Term Debt Repaid
--0.4-0.23-0.45--
Lease Payments
-0.4-0.4-0.23-0.45--
Net Debt Issued (Repaid)
0.720.721.43-0.45--
Issuance of Common Stock
16.548.38472.361.98-3.4
Common Dividends Paid
-171.86-353.23---111.39-84.56
Other Financing Activities
7.32-5.33-10.73-4.3-5.28-1.2
Financing Cash Flow
-147.28-349.47463.06-2.78-116.67-82.36

Net Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Cash Flow
-38.27117.34144.31223.8713.85-7.25

Free Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Free Cash Flow
127.17106.56128.27120.1175.61167.03
Free Cash Flow Growth
12.64%-16.93%6.79%58.86%-54.73%20.59%
Free Cash Flow Margin
22.96%20.29%27.03%25.45%16.55%41.57%
Free Cash Flow Per Share
0.780.660.961.000.631.39
Levered Free Cash Flow
2.4114.87114.93106.55-37.4211.19
Unlevered Free Cash Flow
2.4214.89114.95106.58-37.36211.25
Free Cash Flow After Leases
126.77106.15128.04119.6675.61167.03

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash Income Tax Paid
79.386.1262.8681.7371.6459.18
Change in Working Capital
-53.77-53.772.79-6.92-44.78.44